AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 139 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,789,000 | +455.6% | 118,240 | +175.7% | 0.00% | – |
| Q2 2022 | $322,000 | -94.4% | 42,880 | -93.2% | 0.00% | -100.0% |
| Q1 2022 | $5,753,000 | -19.5% | 632,177 | -37.9% | 0.00% | -25.0% |
| Q4 2021 | $7,144,000 | +390.3% | 1,017,665 | +696.2% | 0.00% | +300.0% |
| Q3 2021 | $1,457,000 | -56.0% | 127,814 | -38.1% | 0.00% | -50.0% |
| Q2 2021 | $3,308,000 | +147.2% | 206,598 | +176.0% | 0.00% | +100.0% |
| Q1 2021 | $1,338,000 | -37.2% | 74,850 | -52.6% | 0.00% | -50.0% |
| Q4 2020 | $2,132,000 | +590.0% | 157,815 | +501.8% | 0.00% | – |
| Q3 2020 | $309,000 | -89.3% | 26,224 | -86.6% | 0.00% | -100.0% |
| Q2 2020 | $2,890,000 | +5.8% | 195,770 | +37.7% | 0.00% | 0.0% |
| Q3 2019 | $2,732,000 | -71.7% | 142,183 | -56.4% | 0.00% | -71.4% |
| Q2 2019 | $9,641,000 | -59.0% | 326,228 | -34.1% | 0.01% | -60.0% |
| Q1 2019 | $23,510,000 | +192.2% | 494,942 | +122.0% | 0.04% | +169.2% |
| Q4 2018 | $8,047,000 | -71.4% | 222,900 | -51.3% | 0.01% | -62.9% |
| Q3 2018 | $28,169,000 | +60.8% | 457,655 | +76.4% | 0.04% | +52.2% |
| Q2 2018 | $17,521,000 | -16.8% | 259,379 | -33.2% | 0.02% | -17.9% |
| Q1 2018 | $21,070,000 | -17.7% | 388,391 | -9.3% | 0.03% | -20.0% |
| Q4 2017 | $25,595,000 | +30.1% | 428,355 | +5.8% | 0.04% | +16.7% |
| Q3 2017 | $19,673,000 | -20.9% | 404,798 | -14.5% | 0.03% | -31.8% |
| Q2 2017 | $24,880,000 | -49.5% | 473,456 | -56.4% | 0.04% | -51.1% |
| Q1 2017 | $49,275,000 | +48.6% | 1,086,545 | +24.0% | 0.09% | +30.4% |
| Q4 2016 | $33,153,000 | +260.1% | 875,902 | +259.0% | 0.07% | +360.0% |
| Q3 2016 | $9,207,000 | -35.4% | 243,958 | -58.3% | 0.02% | -50.0% |
| Q4 2015 | $14,242,000 | -65.2% | 584,877 | -74.6% | 0.03% | -62.0% |
| Q3 2015 | $40,901,000 | +715.2% | 2,305,553 | +711.1% | 0.08% | +777.8% |
| Q2 2015 | $5,017,000 | -78.9% | 284,251 | -62.6% | 0.01% | -80.0% |
| Q1 2015 | $23,798,000 | +497.8% | 759,341 | +456.7% | 0.04% | +462.5% |
| Q4 2014 | $3,981,000 | +142.4% | 136,392 | +71.8% | 0.01% | +100.0% |
| Q3 2014 | $1,642,000 | +83.1% | 79,368 | +119.2% | 0.00% | +100.0% |
| Q2 2014 | $897,000 | -53.3% | 36,203 | -66.1% | 0.00% | -66.7% |
| Q4 2013 | $1,921,000 | – | 106,940 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|